Pyridostigmine Bromide Solution
Product Images NDC 69238-1731

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 69238-1731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Pyridostigmine Bromide Oral Solution Usp 1)

Structural Formula (Pyridostigmine Bromide Oral Solution Usp 1)
This text appears to be a chemical formula consisting of two parts: "OCON(CH)" and "Br-". However, the first part is not a valid chemical formula as it is missing a suffix after "CH". Therefore, it is not possible to provide a useful description based on this text.*
FDA Label Image

Label (Pyridostigmine Bromide Oral Solution Usp 2)

Label (Pyridostigmine Bromide Oral Solution Usp 2)
Pyridostigmine Bromide Oral Solution is an FDA-approved medication containing 60 mg of pyridostigmine bromide, used to relieve weakness and fatigue in patients with myasthenia gravis. It is manufactured by Amneal Pharmaceuticals LLC, Bridgewater, NJ, and comes in a 1-pint bottle (473 ml). The usual dosage may range from one to 25 or more teaspoonful doses per day, depending on the severity of the condition and the needs of the individual, with cautious prescribing necessary based on additional dosage information present in the accompanying insert. It is suggested to store this medication at temperatures between 20°C to 25°C (68°F to 77°F) and should be kept in tight, light-resistant containers. This oral solution is available only by prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.